XEN1101

Drug identity checked against registry records

Also recorded as Azetukalner

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresNCT05667142XENEPhase 3Recruiting2027-04Estimated
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresNCT05614063XENEPhase 3Completed2026-01-12Actual
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)NCT05716100XENEPhase 3Recruiting2028-01Estimated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal EpilepsyNCT03796962XENEPhase 2Active not recruiting2021-09-02Actual
An Open-label Study of XEN1101 in EpilepsyNCT05718817XENEPhase 3Enrolling by invitation2033-04Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.